Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response-Reference-Cited by-同舟云学术

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response

Published:2014-04 Issue:4 Volume:60 Page:748-756
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Vierling John M.,Davis Mitchell,Flamm Steven,Gordon Stuart C.,Lawitz Eric,Yoshida Eric M.,Galati Joseph,Luketic Velimir,McCone Jonathan,Jacobson Ira,Marcellin Patrick,Muir Andrew J.,Poordad Fred,Pedicone Lisa D.,Albrecht Janice,Brass Clifford,Howe Anita Y.M.,Colvard Lynn Y.,Helmond Frans A.,Deng Weiping,Treitel Michelle,Wahl Janice,Bronowicki Jean-Pierre

Publisher

Elsevier BV

Subject

Hepatology

Reference15 articles.

1. Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial;Jensen;Ann Intern Med,2009

2. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy;Poynard;Gastroenterology,2009

3. Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy;Parise;Braz J Infect Dis,2006

4. Re-treatmen t of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40kDa) and ribavirin;Berg;J Viral Hepat,2006

5. Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy;Sherman;Gut,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthroughs in hepatitis C research: from discovery to cure;Nature Reviews Gastroenterology & Hepatology;2022-05-20

2. Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?;Archivum Immunologiae et Therapiae Experimentalis;2021-09-16

3. Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment era;Immunological Reviews;2018-08-11

4. Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España;Gastroenterología y Hepatología;2017-08

5. Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain;Gastroenterología y Hepatología (English Edition);2017-08